Centene Co. (NYSE:CNC) Shares Bought by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB increased its holdings in Centene Co. (NYSE:CNC) by 15.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 24,294 shares of the company’s stock after purchasing an additional 3,200 shares during the period. E. Ohman J or Asset Management AB’s holdings in Centene were worth $1,472,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. Mount Yale Investment Advisors LLC raised its holdings in Centene by 2.1% in the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock valued at $608,000 after acquiring an additional 167 shares in the last quarter. Aptus Capital Advisors LLC raised its stake in shares of Centene by 6.2% in the 3rd quarter. Aptus Capital Advisors LLC now owns 3,722 shares of the company’s stock valued at $280,000 after purchasing an additional 217 shares in the last quarter. CX Institutional lifted its position in shares of Centene by 7.3% during the third quarter. CX Institutional now owns 3,919 shares of the company’s stock worth $295,000 after purchasing an additional 266 shares during the last quarter. Forte Capital LLC ADV grew its stake in Centene by 5.5% in the third quarter. Forte Capital LLC ADV now owns 5,320 shares of the company’s stock worth $400,000 after purchasing an additional 275 shares in the last quarter. Finally, GAM Holding AG increased its holdings in Centene by 0.3% in the third quarter. GAM Holding AG now owns 88,973 shares of the company’s stock valued at $6,698,000 after buying an additional 288 shares during the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Price Performance

Shares of NYSE:CNC opened at $61.36 on Wednesday. The company has a market cap of $30.98 billion, a P/E ratio of 10.65, a price-to-earnings-growth ratio of 0.85 and a beta of 0.45. The company’s fifty day moving average is $61.24 and its two-hundred day moving average is $67.14. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a 12-month low of $55.03 and a 12-month high of $81.42.

Centene (NYSE:CNC) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.31. The firm had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a return on equity of 13.32% and a net margin of 1.90%. The business’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.45 EPS. Equities analysts expect that Centene Co. will post 6.82 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Stephens decreased their target price on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a research report on Friday, December 13th. Truist Financial lowered their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. StockNews.com raised shares of Centene from a “buy” rating to a “strong-buy” rating in a report on Monday, January 27th. Sanford C. Bernstein dropped their price objective on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Finally, JPMorgan Chase & Co. restated an “overweight” rating and issued a $75.00 target price (down from $80.00) on shares of Centene in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $81.31.

Insider Buying and Selling at Centene

In related news, Director H James Dallas purchased 1,693 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were acquired at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the purchase, the director now owns 1,693 shares of the company’s stock, valued at $99,903.93. The trade was a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sarah London acquired 4,117 shares of Centene stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 45,010 shares of company stock worth $2,660,276. 0.29% of the stock is currently owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.